Guangdong Hybribio Biotech Co Ltd operates within the Diagnostic substances sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Guangdong Hybribio Biotech Co Ltd with three other
companies in this sector in CHINA :
Beijing Strong Biotechnologies Inc
sales of 840.86 million Chinese Renmimbi [US$124.96 million]
of which 100%
was Medical Treatment and Public Health),
Getein Biotech Inc
(968.20 million Chinese Renmimbi [US$143.88 million]
of which 80%
was In-vitro diagnostics), and
Beijing Leadman Biochemistry Co Ltd
(515.14 million Chinese Renmimbi [US$76.56 million]
of which 97%
was Biological and Pharmaceutical Products).
During the year ended December of 2019, sales at
Guangdong Hybribio Biotech Co Ltd were 729.39 million Chinese Renmimbi (US$108.40 million).
increase of 25.7%
versus 2018, when the company's sales were 580.35 million Chinese Renmimbi.
This was the fifth consecutive year of sales increases at Guangdong Hybribio Biotech Co Ltd
(and since 2014, sales have increased a total of 176%).
Sales of Medical Testing Servicee saw an increase
that was more than double the company's growth rate: sales were up
69.3% in 2019, from
56.41 million Chinese Renmimbi to 95.52 million Chinese Renmimbi.